Moleculera Biosciences Revenue and Competitors
Employee Data
- Moleculera Biosciences has 13 Employees.
- Moleculera Biosciences grew their employee count by -7% last year.
Moleculera Biosciences's People
Name | Title | Email/Phone |
---|
Moleculera Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.8M | 5 | 0% | N/A | N/A |
#3 | $17.4M | 112 | 3% | N/A | N/A |
#4 | $0.8M | 5 | 0% | N/A | N/A |
#5 | $65.3M | 301 | -3% | $42.5M | N/A |
#6 | $7.9M | 51 | 4% | N/A | N/A |
#7 | $2.8M | 18 | 0% | N/A | N/A |
#8 | $3.6M | 60 | 58% | $14M | N/A |
#9 | $1.4M | 9 | 0% | N/A | N/A |
#10 | N/A | 13 | -7% | N/A | N/A |
What Is Moleculera Biosciences?
Moleculera Biosciences is a precision medicine company focused on identifying and directing treatment for immune-mediated causes of chronic debilitating disorders. Through our fully-accredited CLIA/COLA clinical laboratory, we specialize in molecular diagnostic testing for autoimmune neuroimmunology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain Panel™, an aid to a physician’s diagnosis of autoimmune-based neuropsychiatric disorders.\n\nThe Autoimmune Brain Panel™ helps identify whether an individual’s neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections.
keywords:N/AN/A
Total Funding
13
Number of Employees
N/A
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 13 | -19% | $13M |
#2 | $1.7M | 13 | -13% | N/A |
#3 | $1.9M | 13 | -48% | N/A |
#4 | $2M | 13 | 0% | N/A |
#5 | $1.1M | 13 | N/A | N/A |